Considering that the top hit among enriched pathways in the BPTF signature was aberrant glycolysis metabolism, as shown in Figure 5F, we sought to confirm that the METTL14/BPTF axis regulates the RCC glycolytic process. This evidence concerns the gene METTL14 and renal cell carcinoma.